{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin+Dose+Level+1&page=2", "query": { "intervention": "Pregabalin Dose Level 1", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pregabalin+Dose+Level+1&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T18:26:20.664Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00385671", "title": "An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Neuropathy, Painful" ], "interventions": [ { "name": "duloxetine hydrochloride", "type": "DRUG" }, { "name": "pregabalin", "type": "DRUG" }, { "name": "gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 407, "start_date": "2006-09", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2011-07-26", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 5, "location_summary": "Torrance, California • Cromwell, Connecticut • Staten Island, New York + 2 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Cromwell", "state": "Connecticut" }, { "city": "Staten Island", "state": "New York" }, { "city": "Greenville", "state": "North Carolina" }, { "city": "Midvale", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00385671" }, { "nct_id": "NCT04265456", "title": "A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Pregabalin 100mg", "type": "DRUG" }, { "name": "Acetaminophen 1300mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nevakar, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 63, "start_date": "2020-01-14", "completion_date": "2020-07-22", "has_results": false, "last_update_posted_date": "2020-08-05", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 1, "location_summary": "Pasadena, California", "locations": [ { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04265456" }, { "nct_id": "NCT00551135", "title": "Surgical Pain After Inguinal Hernia Repair (SPAIHR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain, Postoperative", "Hernia, Inguinal" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "17 Years", "maximum_age": "75 Years", "sex": "MALE", "summary": "17 Years to 75 Years · Male only" }, "enrollment_count": 425, "start_date": "2008-01", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2021-01-25", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Glendale, California • Laguna Hills, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Lake Worth", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00551135" }, { "nct_id": "NCT00584376", "title": "Pregabalin (Lyrica) for the Treatment of Essential Tremor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Essential Tremor" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 29, "start_date": "2007-12", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2012-06-18", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Tampa, Florida • Atlanta, Georgia + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Springfield", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00584376" }, { "nct_id": "NCT00643760", "title": "A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuropathy, Diabetic" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "GEn 1200mg/day", "type": "DRUG" }, { "name": "GEn 2400mg/day", "type": "DRUG" }, { "name": "GEn 3600mg/day", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 421, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2013-07-22", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 90, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Dothan, Alabama + 81 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643760" }, { "nct_id": "NCT01389596", "title": "A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy, Partial Seizures" ], "interventions": [ { "name": "Pregabalin add-on therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "4 Years to 16 Years" }, "enrollment_count": 295, "start_date": "2011-09-27", "completion_date": "2016-08-10", "has_results": true, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 20, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 10 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Loxahatchee Groves", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01389596" }, { "nct_id": "NCT03472469", "title": "MAST Trial: Multi-modal Analgesic Strategies in Trauma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Nonspecific Pain Post Traumatic Injury" ], "interventions": [ { "name": "Acetaminophen IV/PO", "type": "DRUG" }, { "name": "Acetaminophen PO", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Celebrex", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Opioids", "type": "DRUG" }, { "name": "Regional anesthesia", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 1561, "start_date": "2018-04-02", "completion_date": "2019-07-03", "has_results": true, "last_update_posted_date": "2021-06-18", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03472469" }, { "nct_id": "NCT01463306", "title": "A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy, Partial Seizures", "Epilepsy, Primary Generalized Tonic-Clonic Seizures" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "66 Years", "sex": "ALL", "summary": "1 Month to 66 Years" }, "enrollment_count": 605, "start_date": "2012-02-21", "completion_date": "2019-08-22", "has_results": true, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 21, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 16 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Loxahatchee Groves", "state": "Florida" }, { "city": "North Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01463306" }, { "nct_id": "NCT01511640", "title": "Behavioral Effects of Pregabalin and Cannabis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Cannabis-use Disorders" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joshua A. Lile, Ph.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 30, "start_date": "2017-02-01", "completion_date": "2020-03-15", "has_results": true, "last_update_posted_date": "2021-09-10", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01511640" }, { "nct_id": "NCT00676403", "title": "Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Restless Legs Syndrome" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 137, "start_date": "2008-04", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2021-02-10", "last_synced_at": "2026-09-27T18:26:20.664Z", "location_count": 15, "location_summary": "Tuscaloosa, Alabama • Little Rock, Arkansas • San Diego, California + 12 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00676403" } ] }